AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List

SAj 12 Days of Holiday Cheer! Day 3: 9th Most Viewed

by

12 Days of Holiday Cheer – Celebrating Some of Our Best!

Day 3: 9th Most Read/Viewed:

Advanced Practice Nurses: Increasing Access to Opioid Treatment by Expanding the Pool of Qualified Buprenorphine Prescribers

Matthew Tierney, MS, PMHNP-BC; Deborah S. Finnell, DNS, PMHNP-BC, CARN-AP, FAAN; Madeline A. Naegle, PhD, CNS-PMH, BC, FAAN; Colleen LaBelle, BSN, RN-BC, CARN; & Adam J. Gordon, MD, MPH

SAj Volume 36, Issue 4

Abstract: This editorial is an appeal for all advanced practice nurses with appropriate prescriptive privileges and DEA licenses to be allowed to join physicians in prescribing buprenorphine to increase access to opioid agonist treatment and to reduce the harms associated with the opioid epidemic. Constituting a large proportion of US health care providers, advanced practice nurses can help stop this epidemic.

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!

SAj 12 Days of Holiday Cheer! Day 2: 10th Most Viewed

by

12 Days of Holiday Cheer – Celebrating Some of Our Best!

Day 2: 10th Most Read/Viewed:

Eight Stages in Learning Motivational Interviewing
William R. Miller PhD & Theresa B. Moyers PhD

Abstract: Motivational interviewing (MI) is a clinical method for helping people to resolve ambivalence about change by evoking intrinsic motivation and commitment. Based on our research and experience in providing training on MI, practitioners acquire expertise in this method through a sequence of eight stages: (1) openness to collaboration with clients’ own expertise, (2) proficiency in client-centered counseling, including accurate empathy, (3) recognition of key aspects of client speech that guide the practice of MI, (4) eliciting and strengthening client change talk, (5) rolling with resistance, (6) negotiating change plans, (7) consolidating client commitment, and (8) switching flexibly between MI and other intervention styles. These key skills are acquired roughly in order, with earlier steps representing logical prerequisites for later stages of skill acquisition.

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!

SAj 12 Days of Holiday Cheer! Day 1: Our Top Tweets of 2019

by

12 Days of Holiday Cheer – Celebrating Some of Our Best!

Day 1: Our Top Tweets of the Year:

  • December 2019: “Excited 2 be again @ #DIScience19. Saddened 2 again see a relative lack of #addiction#impsci presented- considering the #opioidaddiction prom in US. Kudos 2 several of our authors who are presenting some work. #impsci is one of #saj themes. Happy 2 chat 2 any potential authors”
  • October 2019: “Over 300 registrants so far. Is this the biggest ASHR ever? #AHSR2019. Looking forward to seeing young and old scholars, new and old friends.”
  • September 2019: “@back2brains The NIH and particularly NIDA prefers MOUD. MAT can be used only if you are referring to Medication Addiction Treatment. There is nothing “assisted” about it. Many journal editors are now suggesting this term.”
  • August 2019: It was a quiet month – forgive us!
  • June 2019: “CONGRATS to the authors and the readers of @SubstanceAbuseJ Our 2018 Impact Factor (IF) reached 3.0 (2.986). Only a handful of journals in our field are higher. Here are our latest metrics.”
  • May 2019: “Looking forward to this conference and advancing the dissemination of quality #AHSR2019 and #addiction and #healthservicesresearch from the conference. Deadline is May 10, 2019. Submit your work early!”
  • April 2019: “Don’t forget about the @AMERSA_tweets abstract and travel award deadlines of MAY 1, 2019. It should be a great meeting in Boston. All accepted abstracts will be published in @SubstanceAbuseJ but you need to submit to be accepted to be published!”
  • February 2019: “No end to the crisis without an end to the waiver: “Perhaps more importantly, as long as additional training [under #DATA2000] is required, the #buprenorphine treatment itself will remain stigmatized and separate from mainstream health care practice.”
  • January 2019: Another quiet month – give us a break, it was dark and cold!

We hit another top milestone this year! We got to nearly 4,000 twitter followers! Thanks for the follows, likes, retweets, and comments this year!

If you don’t already follow us over on twitter, why not? You are missing out on some big things! Head over and follow us now!

The Authors’ Own Words: Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

by

The Authors’ Own Words:  

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work. 

Lifetime Marijuana and Alcohol Use, and Cognitive Dysfunction in People with Human Immunodeficiency Virus Infection

Sara A. Lorkiewicz, MS; Alicia S. Ventura, MPH; Timothy C. Heeren, PhD; Michael R. Winter, MPH; Alexander Y. Walley, MD, MSc; Meg Sullivan, MD; Jeffrey H. Samet, MD, MA, MPH; & Richard Saitz, MD, MPH

Substance Abuse Vol. 39, Iss. 1, 2018

“Alcohol and other drug use are common among people with HIV infection.  HIV can be neurotoxic, alcohol is a known neurotoxin and marijuana can alter brain metabolism and affect neuronal networks.  In this study, although effects of alcohol use were not detected, current marijuana use was associated with cognitive dysfunction.  The association is particularly important because people with HIV infection may already be susceptible to cognitive dysfunction, and such dysfunction could interfere with their self-care and quality of life.”

Follow us on twitter to stay up to date with SAj, upcoming publications, and more!